Search results
The PLAC® test for Lp-PLA 2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA 2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum.
Lp-PLA2 Activity - Lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet activating factor Acetylhydrolase, is an inflammatory enzyme that circulates bound mainly to low density lipoproteins and has been found to be localized and enriched in atherosclerotic plaques.
Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Test Code: 1257: Test Description: The ProstateDx Clear™ Panel examines genes associated with an increased risk for prostate cancer. This test includes both well-established prostate cancer susceptibility genes, as well as candidate genes with limited evidence of an association with prostate cancer. Genes Tested:
Cardio IQ® Lp-PLA2 Activity - Lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet activating factor Acetylhydrolase, is an inflammatory enzyme that circulates bound mainly to low density lipoproteins and has been found to be localized and enriched in atherosclerotic plaques.
Lp-PLA 2, or lipoprotein-associated phospholipase-A 2, measures disease activity within the artery wall below the collagen or calcified cap due to the activation of macrophages. Lp-PLA 2 is not an acute-phase reactant. When disease is active in the artery, increased levels of Lp-PLA 2 are produced by macrophages and foam cells
2 maj 2023 · Cardio IQ® Lp-PLA2 Activity - Lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet activating factor Acetylhydrolase, is an inflammatory enzyme that circulates bound mainly to low density lipoproteins and has been found to be localized and enriched in atherosclerotic plaques.
